coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Choc (congleton & Holmes Chapel) PCN, Cheshire East (LAD) · Health Inequalities Profile

    PCN U98152 · NHS Cheshire and Merseyside Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    49,899

    Registered population

    56.4% aged 18–64

    25.5%

    Aged 65+

    ICB 19.0% · England 17.9%

    3.3%

    Ethnic minority (non-White)

    1.2% Asian · England 9.6%

    5.2%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~2,627

    Core20 residents (est.)

    Resident basis; registered basis ~2,647 · see page 3

    8,836

    Hypertension register

    +6.99% in 3 yrs · England +5.60%

    438

    SMI register

    11.1% of Cheshire East (LAD)'s

    916

    COPD register

    Reviews -6.00% in 3 yrs

    Forecast to 2030

    10,599

    Hypertension patients, 2030

    +1,763 on today

    67.1%

    QRISK ≥20% on statins, 2030

    +3.49pp over 3 yrs

    6.3%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    64.0%
    Under-80 blood pressure and lipid control lag.

    Under-80 BP control is 64.0% (England 67.8%) after a -5.9% three-year change, while QRISK ≥ 20% lipid therapy is 59.5% (England 63.6%).

    76.9%
    Screening and childhood vaccination exceed national rates.

    Breast screening reaches 76.9% (England 69.9%), cervical screening aged 25-49 reaches 76.3% (England 66.8%), and age-5 MMR1 reaches 99.2% (England 91.7%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Adults aged 65+ make up 25.5% of the list, well above England's 17.9%

    CHOC (CONGLETON & HOLMES CHAPEL) PCN registers 49,899 patients, with 25.5% (12,711) aged 65+, above Cheshire East (22.6%), the ICB (19.0%) and England (17.9%). Patients aged 18-64 comprise 56.4% and aged 0-17 represent 18.2%. Projected list growth to 2030 is 3.6% (England 2.3%), with unverified projection methodology. Census usual residents are 96.7% White and 3.3% ethnic minority groups. Recorded learning disability prevalence is 0.4% (195 patients), below Cheshire East (0.5%) and England (0.6%).

    Age profile

    0–1718.2%
    18–6456.4%
    65+25.5%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White96.7%
    Mixed1.4%
    Asian1.2%
    Black0.3%
    Other0.3%

    Older people · falls rows are Cheshire East (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Cheshire East LA)2,1292,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)81.2%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)60.5%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Cheshire East LA)9391,0219552024/25
    Falls deaths, all ages, per 100,000 (Cheshire East LA)14.818.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation averages 5.2% in the PCN, spanning 10.2 percentage points across practices

    The PCN Core20 share is 5.2%, below England (21.0%), Cheshire East (9.2%) and the ICB (31.9%), with an average IMD decile of 7.5. Practice shares span 10.2 percentage points: Lawton House Surgery has 10.2% (1,357 estimated patients), Meadowside Medical Centre 6.3% (549 estimated patients), Readesmoor Medical Group Practice 5.0% (741 estimated patients), and The Health Centre (holmes Chapel) 0.0%. Resident Core20 estimates total 2,627, while practice estimates sum to 2,647. Deprivation concentrates in Lawton House Surgery, holding the highest share and largest patient volume.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Lawton House10.2% · 1,357 patients
    Meadowside6.3% · 549 patients
    Readesmoor5.0% · 741 patients
    (holmes Chapel)0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    438

    SMI register

    0.89% recorded prevalence

    195

    Learning disability register

    0.40% recorded prevalence

    14

    Care homes, 588 beds

    In the PCN catchment

    8.8%

    Provide unpaid care

    Cheshire East (LAD), Census 2021

    Recorded severe mental illness prevalence is 0.9% (438 patients; England 1.0%). The PCN catchment contains 14 care homes with 588 beds, though bed capacity does not establish registered resident numbers. Cheshire East local authority data records 10 people sleeping rough in 2025 and an 8.8% unpaid carer rate, yielding an estimated ceiling of 4,391 carers that cannot be directly extrapolated to registered patients.

    Severe mental illness: physical health checks

    Severe mental illness prevalence is 0.9% (England 1.0%). Blood pressure checks reached 78.5% (England 83.4%), with Readesmoor Medical Group Practice at 68.4%. Recorded BMI reached 75.4% (England 82.1%), with Readesmoor at 54.7%.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    8,836

    Hypertension register

    +6.99%

    Register growth, 3 yrs

    Cheshire East (LAD) +6.54% · England +5.60%

    −4.03pp

    BP control, under 80

    ≤140/90 · −0.62pp aged 80+

    +1,763

    More patients by 2030

    Forecast 10,599 (20.51%)

    Hypertension case-finding and control

    Hypertension recorded prevalence is 17.9% (8,836 patients), above Cheshire East (17.3%), the ICB (16.8%) and England (15.2%). Blood pressure control under age 80 is 64.0%, trailing Cheshire East (66.6%), the ICB (66.4%) and England (67.8%), following a 5.9% three-year decline (England +3.2%). At Readesmoor Medical Group Practice, control under 80 is 54.1%. Hypertension treated to target is 68.3% (England 70.3%). Unadjusted registers cannot confirm unmet need, and observation periods are unstated. Lower blood pressure control alongside higher prevalence could reflect treatment optimisation or follow-up gaps, testable via clinical audit.

    Lipids and statins

    Patients with QRISK ≥ 20% on lipid-lowering therapy reach 59.5%, below Cheshire East (61.2%), the ICB (63.2%) and England (63.6%). Statin therapy in diabetes without CVD is 68.3% (England 73.2%). Lower lipid therapy uptake may reflect follow-up gaps, testable via primary prevention audit.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026115,876£1.70£1.71£1.86£196,989
    Cardiovascular (all), 2025151,011£3.47£4.37£3.33£524,008

    For lipid-regulating drugs in 2026, the PCN prescribed 115,876 items at £1.70 per item (spend £196,989), below Cheshire East (£1.72), the ICB (£1.71) and England (£1.86). The PCN spends £18,540 less than at England's unit cost. Lower unit costs do not establish prescribing efficiency.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +3.16%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −1.61%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 1.9% across 916 patients (England 1.9%). Twelve-month COPD reviews fell 6.0% over three years to 73.8% (England +2.8% to 76.4%). Asthma prevalence is 7.3% across 3,411 patients (England 6.6%), where 71.4% had a review in 12 months (England 65.7%), leaving 975 unreviewed. This divergence could reflect review capacity allocation, testable via clinical audit.

    Cancer register and children's immunisation

    Cancer prevalence is 5.1% across 2,493 patients (Cheshire East 4.9%, England 3.8%). Childhood immunisation coverage is high: age-5 MMR dose 1 is 99.2% and dose 2 is 95.8%, reflecting a 3.4 pp dose difference. The 4-in-1 pre-school booster reached 94.9% (England 80.9%), below the 95.0% target by 0.1 pp.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months96.0%

    England 91.0%

    6-in-1 complete primary course at 24 months98.0%

    England 92.2%

    MMR dose 1 at 24 months96.9%

    England 88.3%

    MMR dose 2 at age 595.8%

    England 82.8%

    4-in-1 pre-school booster at age 594.9%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    In 2022, 55.5% of staged cancers across NHS Cheshire and Merseyside ICB (7,482 of 13,490) were diagnosed at stage 1 or 2, in line with England (55.3%) but 19.5 pp below the 75.0% national ambition by 2028. Staged cancers represented 72.8% of all 18,522 registered cancers (England 67.0%). Closing the gap to 75.0% would require about 2,640 extra early-stage cases annually across the ICB. Meanwhile, PCN cancer prevalence reached 5.1% (2,493 patients), with three-year growth of +11.5% (England +9.0%). These figures reflect wider ICB staging rather than PCN delivery. System-wide early staging shortfalls indicate that despite high local recorded cancer prevalence, late diagnosis remains a pathway risk across the wider.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), East Cheshire NHS Trust met the 62-day cancer standard for 53.4% of pathways, 31.6 pp below the 85.0% standard, trailing Mid Cheshire Hospitals NHS Foundation Trust (71.1%), University Hospitals of North Midlands NHS Trust (68.8%), the ICB (76.2%) and England (71.2%). Conversely, 28-day faster diagnosis reached 81.1% (standard 75.0%) and 31-day combined treatment reached 96.3% (standard 96.0%). In diagnostics, 26.6% of MRI patients waited 6+ weeks (England 21.4%), whereas colonoscopy 6+ week waits were 10.8% (England 30.8%). Provider waits reflect acute system pressures rather than PCN performance.

    Pathways within standard (%)East CheshireMid Cheshireof North MidlandsCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)81.0879.9580.6577.2579.32
    31-day treatment (96%)96.3086.2193.8595.7192.50
    62-day referral to treatment (85%)53.4171.1268.8476.2371.16
    Diagnostic waits over 6 weeks (%)East CheshireMid Cheshireof North MidlandsEngland
    MRI26.625.1536.1321.40
    CT11.491.092.869.92
    Echocardiography26.245.5145.3928.48
    Colonoscopy10.8530.3446.5330.83
    Gastroscopy10.2531.8915.4929.02
    All 15 DM01 tests16.1712.7222.9423.14
    Community services activityCheshire East residentsCheshire and Merseyside ICB
    Care contacts72,825541,280
    Referrals18,28097,150
    Patients with a contact21,910146,240

    Community services (residents of Cheshire East), Jun 2026 (provisional). In Jun 2026 (provisional), adults aged 65+ accounted for 60.8% of community service contacts among Cheshire East residents (44,295 of 72,825 contacts). This substantial older-age share is consistent with heavy local community nursing and therapy demand, although the data captures local authority residents rather than registered PCN patients.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access spans 15.8 pp between practices despite uniformly high QOF clinical achievement

    In 2025/26, overall QOF achievement reached 98.6% at Lawton House Surgery and 96.7% at Meadowside Medical Centre (England 92.5%). Clinical-domain achievement was 100.0% at Lawton House Surgery and 98.5% at Meadowside Medical Centre. Vaccination domain achievement spanned 10.0 pp, from 77.7% at Readesmoor Medical Group Practice to 87.7% at Lawton House Surgery (England 55.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    (holmes Chapel)1110.042.5%66.3%87.8%
    Lawton House12610.239.8%66.9%80.7%
    Meadowside896.355.6%70.9%75.1%
    Readesmoor1055.054.1%67.4%72.4%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNCheshire East (LAD)AssetPCNCheshire East (LAD)
    Care homes (catchment)14 (588 beds)n/aSchools (catchment)55n/a
    Children's centres114Places of worship46272
    Libraries216Day centres (VCS)n/a1
    Children and young people (VCS)n/a1Carers support groups (VCS)n/a1
    Primary schools (LA maintained)541Primary academies1478
    Special schoolsn/a5

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Hypertension and lipid review recall

    Across 8,836 hypertension patients (17.9%), under-80 BP control is 64.0% (England 67.8%, -5.9% vs +3.2%; Readesmoor Medical Group Practice 54.1%), and QRISK >= 20% lipid therapy is 59.5% (England 63.6%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    SMI physical health check outreach

    Across 438 SMI patients (0.9%), BP checks are 78.5% (England 83.4%) and BMI checks are 75.4% (England 82.1%); Readesmoor Medical Group Practice recorded 68.4% and 54.7%. For discussion: the PCN could introduce combined physical health check appointments, review template coding, and raise shared care pathways with system partners. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Respiratory annual review recall alignment

    COPD reviews across 916 patients (1.9%) fell 6.0% to 73.8% (England +2.8% to 76.4%); asthma reviews across 3,411 patients (7.3%) reached 71.4% (England 65.7%), leaving 975 unreviewed. For discussion: practices could standardise respiratory recall templates and align annual COPD and asthma review slots with inhaler prescribing checks. Low cost, quick to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Learning disability register review (p2)Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Targeted Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Physical health check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension blood pressure control audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall audit (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Early diagnosis safety netting audit (p7)Cancers diagnosed at stage 1 or 2 (All cancer sites)—ICB
    Telephone triage and access review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Hypertension and lipid review recall (p12)Hypertension register · Hypertension: QOF prevalence · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 2 · SMI physical health check outreach (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN & Practice
    Option 3 · Respiratory annual review recall alignment (p12)COPD register · COPD: QOF prevalence · COPD patients with a review in the last 12 monthsCore20PLUS5 respiratoryPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15